Vaccine News and Research

Latest Vaccine News and Research

Investigative journalist looks at independency of US and British vaccine advisory committees

Experts who sit on national vaccine advisory panels are asked to disclose any industry ties and other conflicts of interest. But an investigation published by The BMJ today finds that disclosure standards differ widely, often leaving the public in the dark.

4 Jun 2021

Clinical trial evaluating mixed COVID-19 vaccine schedules begins at NIH

Vaccination efforts against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus behind the coronavirus disease (COVID-19) pandemic, are well underway in many countries. Over 2 billion vaccines have been administered to date, and campaigns continue to encourage more people to get vaccinated.

4 Jun 2021

New strategy for developing universal flu vaccine

A new study from the University of Chicago and Scripps Research Institute shows that during the last great pandemic--2009's H1N1 influenza pandemic--people developed strong, effective immune responses to stable, conserved parts of the virus.

4 Jun 2021

Study says COVID-19 vaccines passports will likely reduce inclination to accept vaccines

Now, a new study published on medRxiv* preprint server focuses on the quantitative evaluation of the impact of the implementation of vaccine passports for domestic and international travel.

4 Jun 2021

People who received Pfizer-Biontech vaccine have lower antibody levels targeting the delta variant

Levels of antibodies in the blood of vaccinated people that are able to recognise and fight the new SARS-CoV-2 Delta variant first discovered in India (B.1.617.2) are on average lower than those against previously circulating variants in the UK, according to new laboratory data from the Francis Crick Institute and the National Institute for Health Research (NIHR) UCLH Biomedical Research Centre, published today (Thursday) as a Research letter in The Lancet.

4 Jun 2021

Heterologous AstraZeneca and Pfizer vaccines induce strong immune response and T cell reactivity against multiple SARS-CoV-2 variants

Researchers from Germany recently analyzed a cohort of 26 individuals in the age range of 25 to 46 (median 30.5) years who had received a ChAdOx1 nCoV-19 prime vaccine followed by a BNT162b2 boost vaccine after a 56-day interval due to changing vaccine recommendations in Germany. There were 16 females and 10 males in the cohort, and they were assessed for immune responses, reactogenicity, and T cell reactivity. This study is published on the medRxiv* preprint server.

3 Jun 2021

Study explores COVID-19 vaccine beliefs and behaviors among college students

A recent study conducted by researchers at Pennsylvania State University in the US explored the beliefs and attitudes of students about vaccination in general and the COVID-19 vaccines in particular.

3 Jun 2021

How can nanomaterials help in the fight against COVID-19?

Researchers have reviewed different types of nanomaterials and how they can be used for the detection, prevention, and treatment of coronavirus disease 2019 (COVID-19).

3 Jun 2021

Researchers develop rapid antibody screening method for novel COVID-19 therapeutics development

New research undertaken by researchers in the USA describes two parallel but distinct in vivo approaches for the accelerated discovery of antibodies targeting SARS-CoV-2 spike protein.

3 Jun 2021

Study compares Pfizer and Moderna mRNA vaccine-elicited response to SARS-CoV-2 variants

A new study has been published on the bioRxiv preprint server which focuses on the correlation between the vaccine-triggered Immunoglobulin G (IgG) levels and neutralization titers against SARS-CoV-2 variants. Further, neutralization activities against the variants (B.1.1.7, B.1.525, and B.1.351), using Pfizer or Moderna vaccine, sera were assessed.

3 Jun 2021

COVID-19 mortality in Israel and Europe after vaccination

The study, which appeared on the pre-print server, medRxiv*, confirms the potent efficacy of COVID-19 vaccination based on real-life public data in terms of protection against death.

2 Jun 2021

Predictors of COVID vaccination uptake in the U.S.

A recent preprint research paper posted to the medRxiv server describes the changing patterns of vaccine uptake in the USA and offers short-term forecasts to help create strategies of vaccine supply as required.

2 Jun 2021

People taking anti-inflammatory drug mount a weaker immune response to COVID-19 vaccine

One-quarter of people who take the drug methotrexate for common immune system disorders -- from rheumatoid arthritis to multiple sclerosis -- mount a weaker immune response to a COVID-19 vaccine, a new study shows.

2 Jun 2021

E484K mutation may confer immune evasion capability on UK variant of SARS-CoV-2

A new medRxiv* preprint reports the immunomodulatory effect of the E484K mutation newly acquired by the United Kingdom (U.K.) variant.

2 Jun 2021

Large-scale expansion of spike-reactive T cells feasible after COVID-19 vaccination

A new bioRxiv* preprint reports on the successful use of a protocol to expand SARS-CoV-2-reactive T-cells a thousand-fold.

2 Jun 2021

Scientists develop a vaccine to protect animals from Salmonella

Researchers at ETH Zurich and the University of Basel have developed a vaccine that protects animals from Salmonella.

2 Jun 2021

Novel SARS-CoV-2 variants partially resistant to infection- and vaccine-induced immunity, study finds

A recent study conducted by a team of scientists in the Netherlands has revealed that while severely affected hospitalized COVID-19 patients and vaccinated individuals are capable of neutralizing the B.1.1.7, B.1.351, and P.1 variants of SARS-CoV-2, a significant proportion of non-hospitalized patients with less severe COVID-19 remain susceptible to these viral variants.

2 Jun 2021

Vaccine News and Research

Latest Vaccine News and Research

Investigative journalist looks at independency of US and British vaccine advisory committees

Clinical trial evaluating mixed COVID-19 vaccine schedules begins at NIH

New strategy for developing universal flu vaccine

Study says COVID-19 vaccines passports will likely reduce inclination to accept vaccines

People who received Pfizer-Biontech vaccine have lower antibody levels targeting the delta variant

Heterologous AstraZeneca and Pfizer vaccines induce strong immune response and T cell reactivity against multiple SARS-CoV-2 variants

Study explores COVID-19 vaccine beliefs and behaviors among college students

How can nanomaterials help in the fight against COVID-19?

Researchers develop rapid antibody screening method for novel COVID-19 therapeutics development

Study compares Pfizer and Moderna mRNA vaccine-elicited response to SARS-CoV-2 variants

COVID-19 mortality in Israel and Europe after vaccination

Predictors of COVID vaccination uptake in the U.S.

People taking anti-inflammatory drug mount a weaker immune response to COVID-19 vaccine

E484K mutation may confer immune evasion capability on UK variant of SARS-CoV-2

Large-scale expansion of spike-reactive T cells feasible after COVID-19 vaccination

Scientists develop a vaccine to protect animals from Salmonella

Novel SARS-CoV-2 variants partially resistant to infection- and vaccine-induced immunity, study finds

New vaccine candidate with RBD and N protein targets protects against SARS-CoV-2 in preclinical trials

From racial justice to dirty air, California’s new AG plots a progressive health care agenda

Can immunity form and interaction with seasonal coronaviruses influence SARS-CoV-2 epidemiology?

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in